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This report from the International Summer School ‘From Genome to Life’, held
at the Institute d’Etudes Scientiﬁques de Carg` ese in Corsica in July 2002, covers
the talks of the invited speakers. The topics of the talks can be broadly grouped
into the areas of genome annotation, comparative and evolutionary genomics, func-
tional genomics, proteomics, structural genomics, pharmacogenomics, and organelle
genomes, epigenetics and RNA. Copyright  2002 John Wiley & Sons, Ltd.
Genome annotation
Steve Brenner (University of California, Berke-
ley, USA) explained the genome annotation chal-
lenge that faces all genome sequencers and those
interested in functional genomics. He pointed out
that it is common for only ∼20% of genes in a
genome to have been studied experimentally prior
to sequencing, and the situation is getting much
worse for some of the bacterial genomes currently
under way. He also pointed out that functional
prediction (although it has been claimed to be
solid in some cases) cannot be certain unless it
is experimentally veriﬁed. Taking the example of
Mycoplasma genitalium, he has compared anno-
tations by TIGR, GeneQuiz (two versions) and
Eugene Koonin. He does see some compatible
annotations, although some have subtle differences
(such as just one method spotting a paralogue or
an incomplete gene). In some cases one method
may use the term hypothetical, another makes an
assumption from the best sequence match. For
some genes two or more methods agree, but in
several cases the results are irreconcilable. Assum-
ing that cases of agreement are correct, the mean
error rate is ∼8%, but he guesses that the actual
error rate is around 20%. The errors can arise from
poor sequence comparison (not true homology),
incorrect inferences from homology, and propa-
gation of erroneous data. He contrasted SWISS-
PROT, which guards against propagation of error
and incorporation of bad data but which does not
give the source of its annotation, and GenBank,
which is ﬁlled with errors but does at least give
the source of the data, enabling users to check it
for themselves. He did, however, point out that, on
occasion, confusing cases where annotation meth-
ods disagree can uncover novel protein functions.
Amongst a range of proteins that were predicted as
nuclear proteins by one tool and as membrane pro-
teins by another, they identiﬁed 53 that had both
transmembrane regions and DNA-binding domains,
making them potential membrane-tethered nuclear
proteins. Many of these are nuclear steroid recep-
tors. They all have a hypothetical cleavage site that
would separate the transmembrane regions from the
DNA-binding domains. Expression of whole and
truncated (DNA-binding domain only) protein for
several examples has demonstrated membrane and
nuclear localization, respectively, as expected.
Hugues Roest-Crollius (Genoscope, Evry, Fra-
nce) presented a summary of the current progress
in Tetraodon nigroviridis sequencing and annota-
tion. In collaboration with the Whitehead Institute
Center for Genome Research (WI), the Genoscope
team have sequenced 8.3 genome equivalents of
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Tetraodon (40% WI, 60% Genoscope), a prelimi-
nary assembly of 5.6 equivalents was released in
May. The assembly is based on in-house software,
which ﬁrst clusters the sequence reads using a fast
algorithm, and then these clusters are provided to
Phrap for assembly. Phrap contigs are then fused,
when possible, and organized into scaffolds. This
latter assembly has been used as the basis for a
preliminary annotation. The annotation is based
on Exoﬁsh and other tools (including Genewise)
and resources (such as a large set of Tetraodon
cDNAs). He presented examples of genes that are
particularly compact, and of genes that are difﬁ-
cult to annotate. The most ‘compact’ gene in their
annotation appears to be the phenylalanine tRNA
synthetase, which is about 340 times smaller in
Tetraodon than in human. The Exoﬁsh approach
(exon ﬁnding by sequence homology) identiﬁes
regions that are conserved in Tetraodon and human,
the alignments falling in coding regions are then
used to build ‘ecores’. Then he presented an update
of the count of human genes based on ecores from
the near-fully sequenced human and Tetraodon
genomes. Their new estimate stands at ∼26000
genes and ∼5000 pseudogenes. He pointed out that
this is in line with recent ﬁndings from projects
such as Ensembl but, interestingly, still lower than
many researchers are prepared to accept. Finally,
he summarized the status of the Tetraodon phys-
ical mapping project. The current map is based
on ∼27000 ﬁngerprinted BAC clones and 2300
markers mapped by hybridization. FISH mapping
is under way to anchor the map onto the Tetraodon
chromosomes.
Gwennaele Fichant (LCB, Marseilles, France)
presented one partial answer to the annotation
problem for bacterial genomes, describing an
approach for identifying, assembling and classi-
fying integrated biological systems from com-
pletely sequenced genomes, which has been tested
on ABC transporters. This in silico reconstruc-
tion relies on an understanding of the compo-
nents of ABC systems. Exporters are made up
of two membrane-spanning domains (MSDs) and
two nucleotide-binding domains (NBDs), whereas
importers have the same structure but with an addi-
tional soluble, or membrane-anchored, solute bind-
ing protein (SBP). In eukaryotes there is one gene
per transporter, but in prokaryotes each compo-
nent is encoded by a different gene. NBDs show
high sequence conservation, in particular of three
motifs, the MSD superfamily shows fuzzy, global
conservation, with 4–8 transmembrane regions,
and the solute binding proteins show no conser-
vation — they are secreted proteins with signal
peptides. Fortunately, the genes are often found
together in bacterial genomes with operon struc-
ture. If they are not in the same operon, they are
usually close by, on a split or neighbouring operon.
Their ﬁrst project was Bacillus subtilis, which had
very few known ABC systems. They found 78
NBDs and 103 MSDs, some of which had the two
parts as a fused gene, and 37 SBPs. Looking for
compatible subfamilies of NBDs and MSDs (e.g.
both with homology to sugar importers) and build-
ing phylogenetic trees of the genes allowed them
to reconstruct 59 complete systems, 10 lone NBDs,
two lone SBPs and 11 pairs of MSDs with an SBP.
Some NBDs are involved in more than one sys-
tem. Since then they have applied the approach to
a wide range of fully sequenced genomes, of bacte-
ria, archaea and Saccharomyces cerevisiae, the data
are available at http://ir2lcb.cnrs-mrs.fr/
Comparative and evolutionary genomics
Olivier Gascuel (LIRMM, Montpellier, France)
gave an overview of phylogeny reconstruction
from sequence data, explaining the basic princi-
ples behind the popular approaches and compar-
ing them.
Phylogenetic approaches are based on multiple
alignments of evolutionarily related sequences and
assume that the changes observed come from
simple mutation mechanisms, such as substitutions,
insertions and deletions. Once the alignment has
been made, gaps are eliminated, identifying blocks
of homology. The alignment is very important to
the end result; a small change in the alignment
can hugely affect the phylogenetic tree result.
The alignment is used to generate a matrix of
differences between the sequences, which can then
be used to build trees.
The parsimony approach is the oldest method.
It aims to identify the most parsimonious tree,
which is the one in which the fewest events have
to be induced to explain the multiple alignment.
It assumes that multiple substitutions are rare and
uniformly distributed. It is easy to calculate the
parsimony of a tree but there are many possi-
ble trees, which makes identifying the best tree
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hard, so heuristic algorithms are usually applied to
ﬁnd the best tree. He gave an example, describing
DNAPARS, which inserts new sequences into a
growing tree in positions that give the most par-
simony, then improves the tree by tree swap-
ping, based on reducing parsimony. Modern mod-
els allow for transitions and transversions and dif-
ferent nucleotide frequencies, and stochastic mod-
els can be used to deal with multiple substitutions.
This approach can deal with 200–300 taxa.
Distance-based methods compute a matrix of
pairwise evolutionary distances between the seq-
uences and build a tree based on the matrix,
using a heuristic approach. This can use the least
squares method, neighbour joining or the minimum
evolution method. It is possible to assign different
costs to different mutations and to make correction
for multiple changes at the same position. It is also
possible to allow for different base compositions
and different rates of base change. Examples of
tools of this type are ADD TREE, NJ, BioNJ
and Neighbor.
In the maximum likelihood approach, a model
of sequence evolution is chosen (which can be
simple or complex) assuming that all sites evolve
independently. The likelihood of the trees is then
computed, based on the multiple alignment, and the
likelihood is maximized. This powerful method is
much slower than distance or parsimony methods,
but usually works better in simulation tests. It can
cope with 100 taxa at best.
He concluded by highlighting some important
points to bear in mind; that gene and species trees
can be very different; the effects of horizontal
transfer of genes on the meaning of trees; and
the difference between duplication and speciation
(paralogues vs. orthologues).
Edward Trifonov (Weizmann Institute, Israel),
gave a presentation entitled ‘Early evolution:
from ﬁrst codons to ﬁrst proteins’. He asked
whether all the amino acids were present to start
with and, if not, which ones were ﬁrst, those which
were more stable, or those with the most stable
codon/anticodon pairs? To answer this, he made a
set of vectors to deﬁne the opinions of researchers
looking at the order of evolution of amino acids
(allowing for agreements and citations). Looking
at the mean ranking of the amino acids — G,
A, D, V, P, S, E, T, etc. — nine of the 10
abiotic amino acids identiﬁed by Miller were
ﬁrst, and at the bottom of the table were the
amino acids with the loosest codon assignment
across species. This showed that the ﬁrst triplets
were the most stable ones, GGC and GCC. New
ones were formed by single base changes from
these and appeared as complementary pairs. As
one might expect, looking at conserved stretches
between bacteria and eukaryotes does detect a bias
towards Gly, and comparing eubacteria against
the others highlights the overall chronology. The
chronology suggests that the earliest oligopeptides
were mosaics of residues from two independent
amino acid alphabets, with the elementary mosaic
unit being six residues long. He proposes that
the next stage of early protein evolution was
to form closed loops of chains, which would
require 20–40 amino acids. This size of loop is
commonly detected in protein crystal structures.
He has derived prototype sequences and secondary
structures of the ancestral proteins and mapped
them onto known proteins and structures (for
further information on this work, see Berezovsky
and Trifonov in this issue, p. 525).
In his talk ‘Origin and evolution of DNA and
DNA replication mechanisms: the viral connec-
tion’, Patrick Forterre (IGM, Universit´ e Paris Sud,
Orsay, France) discussed the growing evidence that
essential enzymatic activities for the production
and replication of DNA have been invented more
than once. Archaeal proteins for DNA replication
are more like those of eukaryotes, despite the mech-
anism being more like that of bacteria. Looking
at Pyrococcus, they saw that the standard route
of uracil metabolism is not used in synthesis of
archaeal DNA; ThyA, the crucial enzyme for the
last step of the pathway where dUMP is converted
into dTMP, is absent. Pyrococcus appears to have
an entirely different, ﬂavin-dependent mechanism
for thymidylate synthesis. Other critical enzymes
in DNA replication appear to have been invented
twice, e.g. the Archaea have an evolutionarily
unrelated family of type II topoisomerases, which
could have been gained from viruses. He then
went on to speak about the switch from RNA
to DNA genomes. DNA is more stable and has
more reliable replication, but these alone cannot
explain the selection of the ﬁrst DNA organism.
He proposed that DNA appeared in the context
of the competition between early RNA cells and
viruses, suggesting that DNA was selected as being
RNAse-resistant in more than one independent
event, and the various DNA metabolism enzymes
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and replication mechanisms then arose in the dif-
ferent lineages. The cells could then use RNAse
to combat viruses. However, viruses then changed
to U-DNA, to evade the RNAse, and eventually
to T-DNA, with the invention of thymidylate syn-
thase. He also commented that evidence indicating
that some eukaryotic nuclear-encoded genes have
come from viruses has recently come to light. He
feels that viruses have played an important role in
evolution and suggested that plasmids may have
originated from viruses.
Andr´ e Goffeau (ENS, Paris, France) presented
a phylogenetic classiﬁcation of yeast membrane
proteins, in particular the transporters. He uses an
adaptation of the transporter classiﬁcation system
established by Milton Saier [5] to make groupings
based on phylogenetic data. The system uses a ﬁve-
digit code; the ﬁrst two digits are used to represent
the class of transporter based on its mechanism, e.g.
1 is for channels or pores, 2 is for permeases (elec-
trochemical potential-driven transporters), and 2A
covers the porters — uniporters, symporters and
antiporters — of which there are 77 families. Class
9 is for incompletely characterized transporter sys-
tems, and he has initiated the use of a class 10 for
membrane proteins that are not transporters. The
next two digits represent the phylogenetic data,
identifying the superfamily and subfamily mem-
bership. The ﬁnal digit is used to identify the
substrate of the transporter. He uses TMHMM to
predict transmembrane proteins and classiﬁes any-
thing with two or more predicted transmembrane
spans. When a new protein cannot be assigned with
high certainty, an ‘x’ is used to indicate unproven
family, ‘y’ to indicate unproven subfamily, and ‘z’
for substrate unknown. Third digits (superfamily)
are assigned if a protein shows a 10% identity
with a probability of E <10−20; fourth digits (sub-
family) are assigned if a protein has 20% identity
with a probability of E < 10−35; and ﬁfth digits
(substrate) at 35% identity with a probability of
E < 10−65. These are arbitrary scores but they have
worked for the genes they have found so far. His
analysis of the S. cerevisiae genes using this phylo-
genetic approach has identiﬁed new families requir-
ing new classiﬁcations. It also highlighted outliers,
unusual genes which are of further interest. Look-
ing at the recent Genolevures data from 16 yeast
genomes, he has identiﬁed 45 transporter families,
including new transporters not found in S. cere-
visiae, which are mainly permeases.
Bernard Labedan (IGM, Universit´ e Paris Sud,
Orsay, France) discussed the merits of taking a
genomic approach to molecular evolution.H e
contrasted the different approaches to building a
phylogeny. The classical approach is to look at just
one gene, across a range of species. Dayhoff sug-
gested using ancient paralogues to allow outgroups
to be made, which help to root this type of tree. The
tree obtained cannot be used to generate a species
tree, but is useful for deducing the history of that
protein. Another approach is to compare all the pro-
teins of one organism (intragenomic). This allows
the detection of all paralogues and all the mod-
ules shared by proteins. His study of Escherichia
coli has shown that duplication and gene fusion
are important mechanisms of protein evolution, and
allowed him to predict the repertoire of modules
that would have been present in the ancestor of
E. coli (for more details on this work, see Zouine
et al., in this issue, p. 493). He then discussed
the intergenomic approach, which is an exhaustive
comparison of all genes across organisms. He pre-
sented his studies comparing E. coli, H. inﬂuenzae,
H. pylori and C. jejuni, searching for all paralogues
and all orthologues. E. coli has the biggest propor-
tion of species-speciﬁc genes, and has more small
families of paralogues, which he thinks may be
needed for survival in adverse conditions. From the
comparison he deduces that the last common ances-
tor of these bacteria had 68.5% of genes that were
unique in that genome and had no orthologues in
other species. The paralogous genes that had ortho-
logues in other species are the class of gene that has
expanded the most since the last common ancestor.
Finally, he discussed the phylogenomic approach,
which is based on the observation that there is
an inverse relationship between the phylogenetic
distance between two species and the evolution-
ary distance separating their orthologues from their
paralogues. He used this to estimate the phylo-
genetic distances for each pair of bacteria. After
calculating the distances, he took the means and
then made a matrix of the means of means, which
he used to build a tree of 56 prokaryotic genomes.
The overall grouping of the bacteria was unchanged
whether he used small or large gene families, but
the speciﬁc order did change. Since the larger fami-
lies tend to be crucial genes across species, whereas
the smaller ones tend to more speciﬁc and can be
due to lateral transfer, he feels that using the larger
families could deal with lateral transfer better.
Copyright  2002 John Wiley & Sons, Ltd. Comp Funct Genom 2002; 3: 535–550.Meeting Highlights 539
Eugene Koonin (NCBI, NIH, Bethesda, MD,
USA) spoke about making evolutionary infer-
ences from whole-genome comparisons.H eﬁ r s t
outlined the history of phylogenetics, starting with
the work in the 1960s of Zuckerhandl and Paul-
ing, who made molecular phylogenetic trees of
cytochrome c and globin. They believed that a true
tree could be built if one had enough sequences.
In the 1980s, Carl Woese made his rRNA trees
producing the standard model of archaea, bacteria
and eukaryotes. He felt that a detailed tree would
be possible if phylogenetic methods were prop-
erly reﬁned. In recent years, W. Ford Doolittle’s
work has uncovered horizontal gene transfer, which
threatens to uproot the tree of life.
Koonin constructs and analyses clusters of orthol-
ogous groups (COGs), which represent ancient con-
served families of proteins. Currently, the resource
covers 58 complete genomes (11 archaea, 46 bac-
teria and one unicellular eukaryote), grouping 105
816 proteins into 4075 COGs. The majority of
prokaryote proteins belong to COGs, but only one-
third of yeast proteins do. Most of the COGs
are represented in only a small number of clades,
providing evidence that horizontal gene transfer
(HGT) and clade-speciﬁc gene loss are important
evolutionary mechanisms. He has produced algo-
rithms to calculate the IQ of each COG, which is
the minimum number of events (gene loss, emer-
gence, or HGT) needed to reconcile the phyloge-
netic pattern of a COG with the topology of the
species tree. The inconsistency of the COGs with
the topology of the species tree indicates the per-
vasiveness of gene loss and HGT; fewer than 10%
follow the tree with no inferred events.
He has explored potential approaches to con-
structing genome trees of prokaryotes. Building
a matrix of the presence/absence of orthologues,
and using this to calculate the least distance to the
common ancestor to form a tree, gave grouping of
bacterial parasites and was not like the tree of life;
it seemed to primarily reﬂect gene loss. Looking at
conservation of gene order (i.e. genes that are adja-
cent in one or more genomes, and separated by less
than three genes in two or more other genomes)
and generating a presence vector to give a tree put
the proteobacteria together and the Gram-positives
together and looked more like the phylogenetic
tree, combining the phylogenetic signal with HGT.
Using the median distance between orthologues
gave a tree more like the phylogenetic tree, in
which some interesting new clades emerge. Making
a concatenated alignment of 32 ribosomal proteins
on which to base the tree gave a tree like the phy-
logenetic tree, with a stronger signal and some new
clades. As a result of this, he identiﬁed three poten-
tial new clades: Aquifex/Thermotoga, Deinococ-
cus/Mycobacteria/Synechocystis and Spirochaet-
es/Chlamydia. Taking a census of trees for mul-
tiprotein families with wide phylogenetic distances
and low numbers of paralogues, he checked the
reliability of these clades by seeing how many
competing topologies there were, and how many
multiple protein families agreed with the clades.
Each test supported the three new clades.
He concluded by saying that he feels that the
concept of a tree of life still makes sense, but it
should not be construed as a full, accurate depiction
of organismal evolution, but rather as a central
trend, which may not apply to the majority of
genes. He thinks that methods based on a more
or less traditional analysis of large sets of well-
selected genes (minimally subject to HGT) can be
informative.
Hiroyuki Ogata (IGS, Marseilles, France) spoke
about a comparative genome analysis of Rick-
ettsia. His group have compared the complete
genome of Rickettsia conorii (which is carried
by ticks and causes Mediterranean spotted fever
in humans) with that of R. prowazekii (which is
carried by lice and causes typhus). There are sig-
niﬁcant differences between the genomes of the
two species; R. prowazekii has just 834 ORFs and
less than 50 repeats, whereas R. conorii has 1374
ORFs and around 650 repeats. R. conorii has actin-
based motility and is not sensitive to penicillin or
erythromycin, unlike R. prowazekii. The compar-
ison shows almost complete co-linearity between
the two genomes, which makes it easy to iden-
tify orthologues. Several genes appear to be split
in one or the other genome, some of which appear
to be able to make functional proteins. There are 30
R. prowazekii-speciﬁc genes (six with remnants in
R. conorii) and 552 R. conorii-speciﬁc genes (229
of these have remnants in R. prowazekii). A R.
prowazekii annotation by the Koonin group identi-
ﬁed 16 genes obtained from the host, 10 of animal
origin, four from fungi, one from plants and one of
unknown origin; he suggested that these might have
come from transfer from the ancestor of Chlamy-
dia, which has 15 genes of plant origin.
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Their analysis also identiﬁed a Rickettsia palin-
drome element (RPE). These ∼150 bp-long stre-
tches would form hairpin loops of secondary RNA
structure; 23 of the 45 copies in R. conorii and
nine of the 10 in R. prowazekii are in ORFs, which
might imply that these are pseudogenes, except for
the fact that several have crucial functions. They
can ﬁnd no evidence of common function for the
genes with the palindromes, but in all cases the
insertions are located in external loops of the pro-
tein structure and do not appear to disrupt func-
tional sites. His group are currently carrying out
experiments to check that these genes encode func-
tional proteins. The RPE sequence evolves faster
than the host gene and the palindrome structure
decays after insertion.
Functional genomics
Titia Sijen (Hubrecht Laboratory, Utrecht, The
Netherlands) spoke about the mechanism of RNA
interference and transposon silencing in Caeno-
rhabditis elegans. RNA interference (RNAi) is a
dsRNA-induced post-transcriptional mechanism of
repression of expression of genes. To use RNAi
to knock down a gene of interest in C. elegans,
it is possible either to inject dsRNA of the gene
into the worms or have them express it from a
transgenic array, or soak the worms in a solu-
tion of dsRNA, or feed them E. coli expressing
the dsRNA. The dsRNA is ‘diced’ into 22 bp-
long siRNA (these are a common factor in the
mechanism in other species) that direct the degra-
dation of the mRNA of that gene. RNAi is inher-
ited by progeny in a process which includes an
ampliﬁcation step, which must be performed by
an RNA-directed RNA polymerase. C. elegans has
four homologues, mutations in all of which affect
RNAi in various ways. Although transposons move
around in somatic cells, this is blocked in the
germ line. The presence of transposon siRNA has
been demonstrated in germ line cells, suggesting
that RNAi is the biological method of defence
against transposons. Large-scale RNAi studies have
been performed in the worm using a library of
E. coli expressing 87% of C. elegans genes. The
results of the phenotypic analyses are available
from Wormbase.
In plants, RNAi is a defence against viral RNAs;
it is possible to make plants resistant to viruses
by giving them viral dsRNA. This could also be
exploited for safely suppressing selected genes, e.g.
to delay fruit softening in tomato. In mammalian
cells there have been problems with aspeciﬁc
responses to the dsRNA, but this has recently been
overcome by using small siRNAs. RNAi is now
being used for gene knockdown for functional stud-
ies, and could be a potential future avenue for gene
therapy against gene speciﬁc transcription. There
are already groups looking at using it against HIV.
Karin Van de Sande (University of York, UK)
presented an overview of the status of functional
genomics in plants and the GARNET project.
In the UK, the BBSRC’s Investing in Gene Func-
tion (IGF) program is funding studies of Arabidop-
sis, brassicas and cereals. Within Europe, the UK,
France and Germany share interests in Arabidopsis
and cereals, amongst other plants, in The Nether-
lands work focuses mainly on Arabidopsis, tomato
and potato, while in Sweden there is a lot of work
done on poplars. The USA has signiﬁcant funding
of plant genomics from the USDA and the NSF;
again, there is much interest in cereals and other
crop plants. In Japan and China plant genomics
focuses mainly on rice and lotus.
GARNET is a project for the functional genomics
of Arabidopsis, which encourages collaborations
between the UK Arabidopsis community. It pro-
vides a wide range of high-throughput user-driven
services and makes data publicly available. There
are services for transcript or metabolite proﬁl-
ing, metabolites, proteomics, forward and reverse
genetics and bioinformatics. The transcript proﬁl-
ing project is resulting in a reannotation of the
genome; they use genome-speciﬁc tags with less
than 70% similarity to other genes (this is only
possible for 70% of the genes). The metabolites
team offer metabolite proﬁling or metabolic ﬁn-
gerprinting. The proteomics service offers a range
of methods in terms of gels and mass spectrome-
try. The forward genetics service uses transposon
mutant lines; they are making over 5000 in the
Columbia and Landsberg erecta ecotypes. They
also have lines for conditional activation. The
reverse genetics team are sequencing the inser-
tion sites of three collections of transposon inser-
tion lines. The Bioinformatics team are building
a database to bring together the data from all
parts of the project and collaborating on inter-
national databases. The PlaNet project aims to
create a network of European plant databases
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(http://mips.gsf.de/proj/planet/). CATMA is one
such European collaborative resource, for Ara-
bidopsis microarrays (http://www.catma.org/).
Stephen Oliver (University of Manchester, UK)
spoke about the integration of functional geno-
mics data for yeast. He described the apparent
redundancy of the yeast genome, which has sev-
eral sets of genes with the same regulation and
protein localization. These do not have qualitative
phenotypes but should have quantitative effects.
One way to measure this is to make metabolic ﬂux
measurements. Typically the enzymes in a path-
way all have small ﬂux control coefﬁcients that
sum to 1; a highly important enzyme would have a
larger ﬂux control coefﬁcient. Of the ∼6000 yeast
ORFs, ∼1000 are lethal upon deletion and show
slow growth in the single mutant diploid (hap-
loinsufﬁciency). The products of these genes are
likely to be important in their pathways. Using the
bar-coded deletion strains and the array of the bar
codes, they are proﬁling the metabolic changes in
these strains. The particular approach that they are
using is called FANCY (functional analysis by co-
responses in yeast), which assumes that when two
mutants have the same co-response, they affect the
same monofunctional unit. If one knows the unit
in which one of the genes functions, then this can
be predicted to be the functional unit of the other.
They have already shown that the method can cor-
rectly group different types of respiratory mutants
based on their metabolic spectra.
Then he described what he calls ‘the big
experiment’, a microarray-based expression proﬁl-
ing of chemostat-controlled yeast growth phases
(slow growth, transition, fast growth and station-
ary phase) under six conditions, including nitrogen,
carbon (glucose), phosphorous and sulphur star-
vation. This has been used to compare the types
of genes and pathways that are involved in the
responses of yeast to each of these conditions. They
have also compared proteomics data with transcrip-
tome data and got a correlation coefﬁcient of ∼0.63
(if one data point was omitted). He was interested
in looking at protein turnover, as he sees this as one
of the missing dimensions of proteomics. By chase
labelling with deuterated leucine in a leucine aux-
otroph, they measured the loss of label over time as
an estimate of protein turnover (degradation rate).
Some proteins were not degraded at an appreciable
rate and they saw no correlation between protein
half-life and mRNA half-life.
Finally, he spoke about GIMS, an object data
model designed to collate international data on
yeast DNA and genes, proteins and protein interac-
tions, expression data, metabolic data, etc. It is cur-
rently available from http://www.cs.man.ac.uk/
img/gims/. ‘Canned’ queries can be combined to
build complex queries and they have already used
it to look at whether interacting protein pairs are
in the same compartment of the yeast cell. 99% of
known complex members did share locations, and
only half of yeast 2-hybrid, or HMS-PCL, or TAP
identiﬁed pairs and complexes did. Their ultimate
aim is a multispecies GIMS; proGIMS (a prokary-
ote version) is already under way.
Monique Bolotin-Fukuhara (IGM, Universit´ e
Paris Sud, Orsay, France) gave a talk enti-
tled ‘Regulatory networks in the yeast Saccha-
romyces cerevisiae: control of oxygen and carbon
metabolism’. In yeast, mitochondrial function is
repressed when the carbon source is glucose, this
must be due to signalling and regulation between
the mitochondrion and the nucleus. YAP1 has been
implicated in the response to oxidative stress and
the HAP complex and HAP1 have been implicated
in regulating the fermentation-respiration shift. Her
group have studied their roles further using yeast
genetics and microarrays.
YAP1 is a yeast c-jun homologue that binds to
the AP1 site, and is known to have direct and indi-
rect target genes. YAP1 deletants are viable but
show hypersensitivity to oxidative stress. Using
LacZ reporter gene fusions and microarrays, they
have shown that during oxidative stress YAP1
upregulates genes that are scavengers of reac-
tive oxygen species and chaperones, as could be
expected, but also that it is required in normoxic
conditions, as it has a role in the control of cell pro-
liferation, like its human homologue, c-jun. They
saw good correlation between the LacZ fusion
data and the microarray data, but the array found
more genes regulated by YAP1 than the fusion
experiments.
They showed that HAP4 induces the expression
of genes involved in the Krebs cycle and mitochon-
drial function when fermentative carbon sources
are limiting or absent. They also identiﬁed genes
that are negatively regulated by HAP4, includ-
ing some genes involved in lipid biosynthesis. It
up- or downregulates ∼450 genes, many of which
have upstream CAT binding sites. Several of these
HAP4-regulated genes appear to be transcription
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factors and she suggested that a systematic study of
transcription factors should be a future aim, to pro-
vide data on the hierarchy of regulatory networks.
Marie Dutreix (Institut Curie, Orsay, France)
presented a study using DNA microarrays to
observe the cellular consequences of growth in
continuous exposure to low doses of ionizing
radiation. At exposures of ∼200 mGy/h, yeast
cells get blocked in G2 phase for some time,
but do eventually restart growth. At ∼20 mGy/h
cells show recombination repair and mutagenesis.
Her group have looked at exposures lower than
this to see what effects there are when growth
is apparently normal. They found that they could
use the array to see very low-level effects; even
at the 0.5 mGy time point they could see small
changes in gene expression compared to controls.
This does depend on the gene, though, as the
level of variation in the data is different for
each gene; some are very variable. Among those
genes that were upregulated, half were of unknown
function, and 10 were involved in the oxidative
stress response, so perhaps the cell is detecting
protein or membrane damage. They did see some
similarities between the time points, but the effects
of this permanent exposure are cumulative and
when they look at the most upregulated genes in
each case they see no overlap. Overall they saw
that 69 genes were overexpressed and more than
155 genes were underexpressed during continuous
low-dose exposure.
Denis Thieffry (University of Aix-Marseilles II,
France) spoke about computational integration,
analysis, and simulation of genetic regulatory
networks. His group have been modelling the Gap
genes involved in Drosophila segmentation. The
Gap module has four genes, which are expressed in
deﬁned domains along the anterior–posterior axis
of the embryo in response to asymmetric maternal
information (the levels and distribution of three
maternal products) in the oocyte. They want to
achieve an understanding of the dynamic behaviour
of the system as a whole. Their model (and those of
others) uses a 4 × 4 grid of the genes to predict the
levels of the four proteins. They tested their model
to see if it could ‘predict’ the levels of the products
correctly for known situations, and showed that it
worked for loss-of-function mutants, if there was
ectopic expression, or for cis-regulatory mutants.
They have also worked on models of the eukary-
ote cell cycle (in the ﬂy) by transposing the yeast
model of Novak and Tyson. They have made a
matrix of the three regulatory proteins plus MPF
and worked out the possible states and transitions
as a graph, which they then use to make predic-
tions. The simulations they have run did correspond
to the correct succession of phases and they have
also correctly simulated a selection of mutants.
Their model has allowed them to deduce that of
the three regulatory proteins, ﬁzzy seems to drive
the oscillations, whereas the others modify them.
Proteomics
Thierry Rabilloud (Grenoble, France) gave an
overview of proteomics by 2D gels and mass spec-
trometry. First he highlighted the scale of the prob-
lem, explaining that a simple prokaryote will have
around 2500 proteins, which are highly modiﬁed,
whereas humans probably have between 100 000
and 1 000 000 proteins, which are heavily modi-
ﬁed. In addition, there can be versions of a protein
with the same number of phosphorylations but in
different places, which cannot be distinguished by
a 2D gel. Mass spectrometry can give some infor-
mation about modiﬁcations, but once you have the
mass peaks, you need to have the full genome
sequence of the organism to identify the protein
that they come from; EST data is not enough and
even mouse–human homology is not enough to
recognize trypsin digest products. Modiﬁed pep-
tides and contaminants will give peaks that do not
match the predictions, which complicates the mat-
ter further. Tandem mass spectrometry allows the
operator to select a peptide of interest and further
fragment it to obtain its sequence (except for Leu
and Ile residues), which can help.
The main problems are the huge dynamic range
of proteins present (it is not possible to resolve
them by any current technique), the huge range of
pI (there are some very basic proteins), the very
hydrophobic proteins (these need a mix of water
and organic solvent) and membrane proteins (these
pose great problems for 2D gel separation). He
is not convinced that subdividing cells into sub-
proteomes helps, since even mitochondrial samples
still show contaminating actin. He also spoke about
comparing transcriptome and proteome data. His
group have compared data sets from studies of
the monocyte to immature dendritic cell transition.
His group have also shown that many transcripts
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were upregulated by RT–PCR (similar results were
obtained by others using microarrays); however,
the proteomics study found that only one of the
proteins encoded by those genes showed increased
expression. They then did RT–PCR on the tran-
scripts for those proteins that did show increased
expression and saw no increase in several of the
transcripts and a decrease in some others.
Finally, he described the MudPIT approach,
which uses a 2D microcapillary column with strong
cation exchange and reverse phase resins to sepa-
rate the proteins, which are then are eluted directly
into a mass spectrometer. MudPIT can identify
many more proteins present in a sample than can
traditional proteomics, but it is not quantitative. So
it depends what information is required as to which
approach should be used.
Pierre Legrain (Hybrigenics, France) described
how in-depth analyses of protein networks can
lead to the discovery of protein function.H e
ﬁrst explained that only ∼500 proteins are known
to be targets of drugs today, and they come from
a narrow set of protein families. It is possible to
implicate proteins as potential new targets, or as a
lead to drop, based on which other proteins they
are related to. Hybrigenics use protein interaction
networks as a way of detecting relationships and
shared functions between proteins; they have an
internal database with 1000s of interacting partners,
from which they have identiﬁed ∼100 potential tar-
gets, of these they have some functional validation
of ∼5 proteins. In their yeast 2-hybrid approach
they run one bait against many prey using a highly
complex library with up to 2–3 million prokary-
ote gene fragments or ∼10 million human gene
fragments. Typically, a few to a few hundred pos-
itives are chosen as selected interacting domains
(SIDs). They use a standard production process to
achieve high throughput and good reproducibility;
many steps in the process are automated.
Their H. pylori studies identiﬁed over 1500
SIDs, and they found 15 of the 16 known Ras
interactions, and four novel ones with genes from
the same families as known interactors, which leads
them to believe that they are true interactions.
Their selection of candidate proteins is computer
aided; they use their PIM Builder LIMS system
and prevalidation tools followed by expert analysis,
including the use of their PIM Rider and Genolink
tools to prioritize targets. The SIDs are mapped
onto proteins and compared to the annotation
of functional domains; where possible, functional
categories are then assigned.
Bertrand Seraphin (CGM, Gif, France) gave
a presentation entitled ‘Proteome analysis and
functional characterization of protein complexes
using the TAP (tandem afﬁnity puriﬁcation)
method’. Several recent large-scale studies have
shown that proteins rarely act alone; many are
found in complexes. Typically, different strategies
have been needed to purify different proteins, so
he wanted to try to design a standard method that
could be broadly applied. The only way to do
this is to use afﬁnity tags and a native method
(mild conditions) that retains complexes. He also
wanted to use only basal expression in the host,
to obtain the normal form of the complex, so the
method had to have strong and speciﬁc binding of
the tag. The tag that was chosen is a calmodulin-
binding peptide separated from two IgG binding
domains of protein A by a TEV protease cleavage
site. This allows a two-step puriﬁcation, using IgG
beads ﬁrst, and then TEV protease cleavage, using
calmodulin-coated beads in the presence of calcium
to obtain the complex. This method drastically
reduces the volume of culture needed from 300 l to
5 l. They tested it on yeast U1 snrps and other yeast
complexes and even obtained some complexes that
still showed activity. They have also shown that it
works in other organisms, including human cells.
To test the approach for large-scale applications,
they teamed up with Cellzome for a global analy-
sis of yeast complexes. They started with the 1739
yeast genes with homologues in other eukaryotes,
of which 589 have so far been successfully puri-
ﬁed using the TAP method, and complexes were
identiﬁed in 232 cases. 58% of the complexes they
found were novel; in 33% of cases they identi-
ﬁed new components of a known complex and in
9% of cases only known components of a complex
were found. They have generated a network of the
complexes which can be colour coded to denote
the functional categories of the complexes; this
did show some grouping of complexes of related
function. In running gels of the complexes, they
saw that the method appears to be at least par-
tially quantitative. This data is lost in the Cellzome
project as the gel is used to generate bands for mass
spectrometric analysis, but he is following this up
in his lab.
Michel Werner (CEA, Saclay France) has used
microarray analysis to study the adaptation of
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the yeast proteome in response to cadmium.
Proteins induced by exposure to cadmium include
antioxidants, heat shock proteins and chaperones.
In the sulphur–amino acid metabolic pathway,
there are pairs of isoenzymes that show oppo-
site regulation by cadmium. Looking at the pro-
teins induced by cadmium, he saw that they have
reduced sulphur content (low Met and Cys), so
this seems to be a sulphur-sparing mechanism. The
glutathione synthesis pathway is strongly induced,
suggesting that perhaps sulphur is redirected into
formation of GSH to complex the cadmium. Look-
ing at the response in more detail using microar-
rays, he saw induction of detoxiﬁcation genes,
DNA repair genes, stress response genes and nitro-
gen and sulphur utilization genes, and repression
of RNA and other transcription, RNA transport,
ribosomal proteins and translation. Comparing data
from RNA and proteins, he concluded that the
response to cadmium is regulated at the transcrip-
tional level. He wondered if it could be sulphur-
containing amino acid transcription factors that reg-
ulate the response. Using the chip he identiﬁed
several cadmium-induced genes that were regu-
lated by Met4p, all of which encode low sulphur
content proteins. However, there are still other
cadmium-induced proteins that have lower than
average sulphur content and that are not regulated
by Met4p, so other transcription factors mediating
the response remain to be found.
Structural genomics
Wolfgang Baumeister (Max Planck Institute fur
Biochemie, Martinsried, Germany) spoke about the
use of electron tomography to visualize super-
molecular architecture inside cells. He thinks that
it is likely that there is structure beyond single
macromolecules in the context of the cell (at nm
scale). Many interactions are too weak or transient
to be studied by biochemical methods; for this, an
in situ approach is needed. Electron tomography
can give 3D images of frozen hydrated cells with
2–4 nm resolution.
The technique has great potential for visualizing
macromolecules inside cells, but this application
is, as yet, in its very early stages. To make a 3D
reconstruction, a set of 2D projections is taken
from a single specimen. However, to obtain a
detailed, undistorted reconstruction, a tilt series
must be taken with as wide an angular range as
possible and with as many increments as possible.
The problem with this is that the electron dose
of the sample must be kept subcritical to make
sure that radiation damage does not erase important
details; a safe dose must be spread across the
sample. It is also difﬁcult to move the sample
accurately by the very small increments needed
to make the series. Typically, ∼150 images are
taken, using 97% of the safe dosage; the rest is
used to correct for inaccurate movement of the
sample. He showed some examples of what can be
done, including a visualization of a 20S proteasome
in a Dictyostelium cell. Other examples are a
thermosome, the GroEL complex and vesicles on
their way through a membrane. The method has
only been applied to two eukaryotic cell types so
far, Dictyostelium and neurons. The diameter of the
cell needs to be less than 0.5 µm to obtain good
r e s u l t s ;ac e l lu pt o1µm diameter can be studied
but for larger cells the method must be combined
with cryosectioning.
Monique Marilley (University of Aix–Marsei-
lles, La Timone, France) spoke about using molec-
ular modelling and atomic force microscopy in
the study of genomes. DNA structure can vary,
which affects the stability and could indicate func-
tion, such as histone binding and packing. To model
the structure taking into account each atom has
limitations, so typically, simpler models with a
reduced number of variable parameters, are used.
Base pairs all have the same dimensions, which
makes mapping the next base pair easier, but the
twist, roll and tilt must all be taken account of.
There are several existing estimates of these param-
eters for any one region, which do not completely
agree, so important questions are how does one
select the best parameters, and how can they be
improved?
In atomic force microscopy a sharp tip is held
above the sample on a movable, cantilever arm.
Deﬂections caused by interactions with the sample
are measured by a photodiode. This then gives 3D
real-time analysis and permits access to the external
envelope of objects under observation. Imaging
can be done in a vacuum, in air or under liquid
(the tip is submerged) and can be used to look
at single molecules or populations of molecules.
Image analysis yields information on the length
of the molecule and the distance between the two
ends; by using end labelling of DNA, its orientation
Copyright  2002 John Wiley & Sons, Ltd. Comp Funct Genom 2002; 3: 535–550.Meeting Highlights 545
can also be determined. She has done experiments
to see if the method can be used to study planar,
or non-planar, curvature of pieces of DNA. In
both cases she has found that imaging under liquid
works better and that her results were conﬁrmed
by gel retardation analysis. So, AFM offers a
new opportunity to study DNA curvature, but the
transformation from the 3D form to 2D must be
taken into account. There are several approaches
to looking at DNA ﬂexibility, DNase I is used to
look at bendability, and nucleosomes to look at
ﬂexibility (commonly these methods agree, except
in certain regions). Crystallography can be used to
look at deformability and AFM in air could be used
to look at ﬂuctuation of experimental measures. She
looked at the binding of an enhanceosome to DNA.
A previous ESI study had shown that the binding
caused one turn of the DNA, so she used AFM in
liquid to predict the most ﬂexible regions. Their
most ﬂexible region matched the binding site of
the molecule.
Herman Van Tilbeurgh (LEBS, CNRS, Gif-sur-
Yvette, France) gave an overview of structural
genomics and then spoke brieﬂy about some exist-
ing structural genomics projects, including the
one for yeast at Orsay-Gif (http://www.genomics.
eu.org/). Current projects are either structure-
directed (building dictionaries of all available pro-
tein folds, or modelling the majority of proteins
in an organism) or function-directed (determin-
ing the structure of proteins of known function
or predicting function from structure). Structural
genomics can provide information on protein fam-
ilies, surface composition, active sites, ligand inter-
actions, mutants, SNPs and conserved residues. It
is clear that we need higher throughput, as we
want to know about the space–time organization
of molecules, alternative structures and dynamic
aspects of structure. Vitkup et al. [6] estimated that
there are 1000–3000 unique types of fold topology;
PDB currently holds ∼300 and it generally takes
data from ﬁve sequences to characterize one fold.
At 4–8 ˚ A resolution, with insigniﬁcant sequence
homology it is only possible to produce ab ini-
tio predictions, with poor conﬁdence. With 30%
sequence similarity and 3.5 ˚ A resolution, it is pos-
sible to obtain 80% modelling accuracy and use
structure threading; this model would allow some
inferences to be made. However, to make more
complex inferences, the accuracy of the model
needs to be around 95%. Data from members of a
family can be combined to deﬁne structural motifs;
these can be used to search for new members of
a family. When a sequence appears to be similar
to known proteins, it is possible to apply struc-
tural superimposition. If the Z score of the match
is good enough, then it is likely to be a member
of the family. He then gave some examples of the
highs and lows of the structure–function paradigm,
including the discovery of a role for cytochrome c
in apoptosis, which had not been predicted despite
a large volume of data on its structure, and the elu-
cidation of the function of an M. jannaschi ATPase
completely from its structure.
Technological developments have been, and will
continue to be, driven mostly by the structural
genomics projects. DNA cloning, expression and
puriﬁcation are in some cases already automated,
except for fragile proteins, and there have been
some improvements in crystallization. In the area
of data collection, the synchrotron technology has
been linked to automated crystal handling and
there have also been improvements in data anal-
ysis programs. In the NMR ﬁeld there have been
advances in the design of spectrometers and in
labelling techniques. The next challenges for struc-
tural genomics are membrane proteins, protein
complexes and proving the value of the struc-
ture–function paradigm.
Dino Moras (IGBMC, Strasbourg, France) gave a
talk on a structural genomics project for orphan
nuclear receptors. Nuclear receptors (NR) have a
modular structure with a highly conserved DNA
binding domain and a less well conserved lig-
and binding domain (LBD), separated by a hinge
region. They regulate transcription in three modes,
repression (with a co-repressor), derepression (with
a co-activator) and activation (with a mediator).
The structures of some NR LBDs have been deter-
mined, and a model canonical structure is known;
to detect some features of the function, however,
requires high resolution. Both the solubility and
the stability of these proteins cause problems, one
solution being to engineer a different form of the
protein. Looking at the vitamin D receptor, they
made an alignment across a range of species and
saw an insertion in some species, so they made two
constructs and saw that one was more stable. The
next stage is to ﬁnd out if they are active using solu-
tion studies. One way of stabilizing the structure
is to determine the structure of the receptor when
it is bound to its agonist or antagonist — ideally
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both of these structures would be determined. Their
research program is targeting 26 orphan receptors
(receptors with no known ligand), and they have
made 70 constructs for this. They have so far
achieved expression of 30% of the constructs; 16%
were soluble and they have been able to purify 14.
To date they have successfully grown crystals of
four receptors and have structures for three. The
next step is to identify the ligand of these recep-
tors; so far they have found the ligand of RORβ
and now they are looking at RORα.
Steve Brenner (University of California, Berke-
ley, CA, USA) gave a talk entitled ‘structural
genomics: classiﬁcation and analysis’ and also
spoke about the structural genomics project at
Berkeley. He started by pointing out the correct
meaning and use of terms such as ‘homology’
and ‘similarity’. Homology denotes an evolutionary
relationship, that two sequences have a common
ancestor; it cannot be measured, it can only be
inferred. Similarity, on the other hand, is a mea-
surement from which one might infer homology.
Orthologues are proteins that are related purely
by vertical descent (separated only by speciation).
Orthology is not a statement about function and is
not deﬁned by best hits of sequence comparisons
(as these will not always ﬁnd the true orthologue).
Paralogues are all other homologous proteins that
are related by duplication.
He explained that structure is better conserved
than sequence, citing haemoglobin and myoglobin
as an example of two proteins with very similar
structures that have been known for many years,
but we have only recently been able to see the weak
sequence conservation between them. The number
of structures in PDB is increasing exponentially
over time. He talked about the SCOP database
(a hierarchical classiﬁcation of structures) as a
way to organize the data. The superfamily ﬁeld
is a key ﬁeld in the database; all proteins from a
superfamily will have the same core structure and
other shared features such as catalytic mechanisms.
He thinks there will be 1000–2000 superfamilies
in total; this relatively small number means that
classifying them is a realistic task that will allow us
to understand all the fundamental units of proteins.
At Berkeley they have a structural genomics
project that is focused on Mycoplasma genitalium
and Mycoplasma pneumoniae. Their target selec-
tion excludes proteins of low complexity and mem-
brane proteins. For the remaining proteins they
deﬁne families and remove those which already
have a structure model (including from another
organism). They then prioritize broadly conserved
families, then those speciﬁc to one of the Mycoplas-
mas, then those that are only in the two Mycoplas-
mas. Next they look for those that are easiest to
characterize, with no UGA (Trp) codons, and which
are easy to clone. Starting with the 677 M. genital-
ium ORFs, they have narrowed down the list to 80
priority proteins and have already published work
on 16 of them. In several cases they have found
a ligand bound in the structure, which has given
them clues as to the function of those proteins.
Finally he spoke brieﬂy about SCOR, a clas-
siﬁcation of RNA structures based on duplexes
(http://scor.lbl.gov). This gives several groups of
structures with varying levels of presence, such
as tetraloops and diloops. Looking over the whole
classiﬁcation, it seems that RNA structure has far
fewer options in terms of structure.
Pharmacogenomics
Olivier Grenet (Novartis, Switzerland) spoke about
the application of genomics to drug develop-
ment. He explained that the use of genomics in
the early stages of drug development, such as in
drug discovery and preclinical tests, is what he
would describe as ‘pharmacogenomics’. The appli-
cation of SNP proﬁling to the trials in human
patients is what he would call ‘pharmacogenetics’.
Genomics can be used for several stages of the
process, such as to drive mechanistic hypothesis,
to uncover potential markers, for safety assessment
of a number of markers and for re-indication of safe
drugs by looking at their proﬁles in genomic exper-
iments. Genomics approaches such as chip-based
gene expression analysis and real-time quantitative
PCR can be used as assays for markers and mech-
anisms of efﬁcacy and toxicity.
They use the Affymetrix chip with 30000 human
genes in expression proﬁling experiments, and the
Spotﬁre and Genespring software and resources
such as GeNet to produce clusters and trees of
genes based on the expression data. For example,
they have proﬁled oestrogen-responsive and non-
responsive breast cancer tumours to deﬁne markers.
They also map metabolic data onto the KEGG
database to look at the regulation of metabolic
pathways under various conditions. They are also
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working on combining datasets and text mining,
e.g. of PubMed. They are building dictionaries
of terms such as gene names, disease names and
function descriptors to build into a ﬁgure of genes
and links between them. They then plan to look for
correlations between this and their expression data.
However, chips cannot always answer questions
about polymorphisms and alternative splicing or
weakly expressed genes, so they also use real-
time quantitative PCR. This method allows them
to study chosen genes and to speciﬁcally monitor
gene variants from only minute samples. Arrays
cannot differentiate between genes that are highly
expressed in a very small number of cells in
a tissue and those that have low expression in
all cells of the sample; for this they turn to in
situ hybridization, primarily of genes of interest
identiﬁed from the arrays. They can use this to look
at the localization of expression and the effects of
time and treatment variations.
Wim Hol (University of Washington, Seattle,
WA, USA) gave a talk about medicinal pro-
tein crystallography and structural genomics
for tropical diseases. Anti-protozoan drugs are
often drugs initially targeted against other dis-
eases or developments of existing drugs. There
are possibilities to look for new drugs, perhaps
targeted at metabolic pathways. Two questions to
consider are: Is protein function sufﬁciently crit-
ical to serve as a target?; and Is the structure
of a crucial protein promising as a drug target?
For instance, does it have a hydrophobic pocket?
He illustrated the value of knowing the structure
of targets with the example of a pentamer toxin
campotecin topoisomerase; a complex compound
with penta-symmetry was designed which success-
fully binds the toxin. Structural genomics requires
careful target selection, high-throughput expres-
sion, crystallization and structure determination.
Key factors in selecting targets are that they be
essential and sufﬁciently unlike any human genes,
or essential and have no human homologues at
all. His group are working as part of an NIH-
funded project, ‘Structural genomics of pathogenic
protozoa’ (SGPP), that has access to two syn-
chrotrons. The project will focus on Trypanosoma
brucei, T. cruzi, Leishmania major and relatives,
and Plasmodium falciparum. They aim to solve
the structures of a large number of water-soluble
proteins and a number of membrane proteins and
protein–protein complexes. Current T. cruzi drugs
are almost useless and have bad side effects, so the
need for solutions is great. At the time of his talk,
the malaria genome was due in August, the genome
of L. major was 30% complete and that of T. bru-
cei only ∼10% complete. The T. brucei genome
is proving a real problem to annotate — the pre-
diction programs don’t agree on their gene pre-
dictions, so there is much work yet to be done.
He also explained that many functional genomics
projects won’t work on parasites and they are not
easily transformed, so much more work needs to be
done on developing technologies and approaches
for these organisms.
George Weinstock (Baylor College of Medicine,
Houston, USA) spoke about using genomics to
understand bacterial pathogenesis in Treponema
pallidum. T. pallidum is a spirochaete with a
periplasmic ﬂagellum and few surface proteins. It is
a stealth pathogen that can disappear and reappear
10 years later in the same patient. As yet there is no
in vitro continuous culture system for it. A relative,
T. denticola, is an oral spirochaete associated with
periodontal disease. It can be cultured in vitro,i ti s
possible to make knockout mutants, and there is a
vector for complementation.
The genome of T. pallidum is ∼1 Mb and has
∼1000 protein encoding genes, 485 of which are
of unknown function. 48 genes are related to vir-
ulence, including Tpr proteins, haemolysins, reg-
ulators, polysaccharide biosynthesis genes, surface
proteins and host interactors. He feels that there
are many more virulence genes amongst those of
unknown function. They are expressing T. pallidum
genes in heterologous systems for antigenicity and
immunogenicity screens. Functional studies on the
haemolysins have shown that they do react weakly
with preimmune sera but most of them do not show
haemolysin phenotypes, so they may not be true
haemolysins. Checking the source of this annota-
tion uncovered a weak and unconvincing homology
in the original assignment. They are also cloning
and expressing all T.pallidum genes in various vec-
tor systems, as GST or His fusions. So far they
have cloned 1008 and have 23 more to complete.
They also plan to use some known antigens and
some new potential antigens for phage display in
rabbits. They have also tried large insert libraries
in E. coli; they saw that at least half of the genes
were expressed, so the promoters must have been
pretty well conserved, despite the large evolution-
ary distance between them.
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Organelle genomes, epigenetics and
RNA
John Allen (Plant biochemistry, Lund University,
Sweden) discussed the function of cytoplasmic
genomes. He explained that it is well known that
proteins are packed into organelles, with very little
space left, so why have a genetic system, when
space is at a premium? It is widely held that
organelle genomes are a relic of their bacterial
origin; most useful genes have been transferred
to the nuclear genome, so why do chloroplasts
and mitochondria retain a genome, when other
compartments such as proteasomes do not? Why
not move all the genes to the host genome? He
detailed several explanations that have been sug-
gested, including that of Bogorad [1] — so that the
core components of multisubunit complexes can be
synthesized de novo in the correct compartment.
Herrman and Westhoff and others have suggested
that it is because the evolutionary process of trans-
ferring genes to the nucleus is still incomplete,
and von Heijne [7] suggested the related ‘frozen
accident’ theory, that the evolutionary process of
transfer was under way and something occurred
that stopped it (although there is no evidence for
this). Some discussions that have led to the sug-
gestion that it is all a question of hydrophobic-
ity, but there are no data to support this; another
unattributed suggestion is that some proteins and
co-factors cannot be imported and therefore must
be encoded in situ. John Allen believes that it is
because it allows redox control of gene expres-
sion, by which he means that the organelle-encoded
genes control the ‘core’ assembly of complexes
and need to be regulated in situ in response to
the dangerous redox chemistry that goes on in
the organelles. He thinks that the nuclear-encoded
genes that are redox-regulated in plants and ani-
mals are regulated in a different way, and that the
subunits encoded by these genes may be periph-
eral. This provides a reason why the mitochondria
should come from the female, since this provides
less chance for mutation and would be safer, with
less risk of alteration in these dangerous genes
(more details of John Allen’s discussion on the role
of organelle genomes can be found in his review
in our next issue).
Philip Avner (Institut Pasteur, France) talked
about a functional genomics approach to X-
inactivation. First he explained that epigenomics
is the study of heritable, stable changes in genetic
activity that are not based on changes in nucleotide
sequence. Such effects are implicated in several
inherited disorders and in the development of can-
cer. X-inactivation is the most extensive epige-
netic mechanism known, which potentially con-
trols 1500–2000 genes on the X chromosome. It
is tightly coordinated with embryogenesis and the
establishment of cell differentiation. It also implies
that there must be recognition of different copies
of the X chromosome in the cell. The inactive X
is transcriptionally silent, and replicates late. It is
depleted in acetylated forms of histones H3 and
H4, and it has hypermethylated CpG islands. Inac-
tivation occurs during early cell divisions of the
embryo and is controlled by a master locus, the X
inactivation centre (Xic). This unique region of the
X chromosome is needed to ensure that only a sin-
gle X is inactivated in each diploid female cell. It is
responsible for choosing which copy is inactivated
and for initiating the nucleation of silent chromatin
on the chosen chromosome. The change from the
active to the inactive state is associated with the
accumulation of a large non-coding RNA (encoded
by the Xist gene, located in the Xic region), which
seems to spread in cis from Xic until it ‘decorates’
the entire inactive X. Silencing occurs rapidly after
the initiation of inactivation and is associated with
extensive modiﬁcations of the chromatin structure
(which are, as yet, poorly characterized).
Genomic studies of the Xic region have identi-
ﬁed several elements, including Xist, Tsix (a 40 Kb
antisense transcript of Xist with a CpG island),
Tsx, and a 5  hotspot that is a region of possible
chromatin nucleation. Female ES cells can be used
as an ex vivo model system to study this mecha-
nism, and they have tried deleting these elements
in these cells. A 65 Kb deletion in the Tsix region
increased the steady-state level of Xist, and resulted
in the mutant copy being the chromosome chosen
for inactivation; it affected the choice and counting
stages of the process. A smaller deletion resulted in
normal levels of Xist; the mutant chromosome was
always chosen for inactivation, as before, and initi-
ation of inactivation was repressed. They concluded
that there are multiple control elements; neither
choice nor counting are mediated solely by Tsix,
but it does regulate the level of Xist. They have
also looked at the 5  region in relation to histone H3
methylation, since histone modiﬁcation is thought
to be associated with active and inactive states of
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chromatin. They showed that a Lys9 methylated
form of H3 is associated with promoters in the
Xic region in females and that the amount of this
form that is associated increases when Xist levels
increase. The association of this form with the pro-
moters is a late event, and early, global methylation
of H3 Lys 9 must affect other loci. It could perhaps
recruit Xist to sites along the chosen X. They have
also looked at the Xic region of the mouse genome.
They have found several protein-coding genes, four
untranslated RNA genes and two retrotransposon
genes. They see an evolutionary selection against
insertion of LINEs in actively transcribed genes
and widespread intergenic transcription of untrans-
lated RNA. The Tsix sequence is not conserved in
humans and neither are all the regulatory regions,
so they can’t predict the pattern of regulation. He
suggested that the role of the non-translated RNA
is likely to be critical for X inactivation.
Eric Westhof (ULP, Strasbourg, France) gave
at a l ko nstructural bioinformatics of struc-
tured RNAs. He explained that RNA motifs fold
autonomously, and that they are recurrent and lim-
ited in number. Each RNA structure can be parsed
into key motifs; the folding is determined by the
laws of chemistry and physics. RNA motifs are
conserved across the tree of life and are used for
diverse functions. Watson–Crick (W–C) base pairs
in RNA make the helices, which form a scaffold,
but the non-W–C pairs dominate the tertiary struc-
ture, making the motifs, and are responsible for
RNA–RNA recognition, etc.
He then described a proposed nomenclature for
non-W–C pairs that avoids ambiguous, redundant,
historical or contingent terms and allows for easy
visualization of the base pair geometry. It also aids
in identifying isosteric relationships and facilitates
homology modelling. It treats bases as triangles
and describes the interacting pairs by which of the
three edges each base uses to make the interaction
(W–C, Hoogsteen, or sugar edge), and the orien-
tation of the bases — cis or trans. He has devised
a series of symbols to denote the possible combi-
nations, which can be used to draw diagrams and
to more easily compare RNA structures (for more
details of this nomenclature and its applications in
the study of RNA structure, see Leontis and West-
hof in this issue, p. 518).
Daniel Gautheret (University of Marseilles, Fra-
nce) gave a presentation entitled ‘RNA bioinfor-
matics: the identiﬁcation of non-coding RNA
in genomic sequences’. He introduced the ﬁeld
of RNomics, which includes non-coding RNA
(ncRNA), coding RNA with functional motifs, and
introns. Non-coding RNA is deﬁned by primary
sequence and secondary structure. Using substi-
tution matrices for nucleic acids to identify them
works very poorly compared to using them to ﬁnd
coding DNA, as pairing of bases in the structure
is more important, so base changes can happen.
This means that BLAST will only ﬁnd a few of
them and hidden Markov modelling is not so good
either. Despite this, all the tRNAs have so far been
found by using BLAST. There are existing tools
for tRNA prediction, for group 1 intron prediction
and for snoRNA prediction, and there are ﬂexi-
ble tools that use human made descriptors to do
a fast database search (although these are time-
consuming and provide only a yes/no answer, with
no scoring). There is a need for probabilistic pre-
dictors; it is not enough to say that a base is paired
as there are base pair biases that are linked to
function, which could escape human inspection.
There have been some studies using stochastic,
context-free grammars, but these were not practical
for large alignments or genome-wide searches and
were costly in terms of time. His group have writ-
ten ERPIN, a proﬁle descriptor of sequence align-
ments that uses classic proﬁles and provides a Lod
score with each prediction, and SECIS, a seleno-
cysteine insertion sequence search tool, which has
been trained on 43 selenoproteins. They used these
tools together, iteratively, on ∼4 Gb of sequence
and predicted 120 sure SECIS hits and 200 poten-
tial hits (see http://tagc.univ-mrs.fr/pub/erpin/).
De novo prediction of ncRNAs is another chal-
lenge. Approaches tested so far include thermody-
namic proﬁling (but this has only had very limited
success) and G + C content, or a combination of
G + C% and CpG%, which worked well only for
high A + T content genomes. RNA Genie [2] was
trained on E. coli DNA sequence, which was split
into a negative set (intergenic regions) and a pos-
itive, true ncRNA, set. It uses a combination of
parameters, including nucleotide and dinucleotide
composition, to make predictions and the group
claim 80–90% accuracy. Other groups have used
comparative genomics to help ﬁnd ncRNAs, such
as the QRNA tool of Rivas and Eddy [3] and the
study of mouse and human intergenic regions by
Shabalina et al.[ 4 ] .
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